← Evidence map

ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

Combined clemastine fumarate and selenomethionine promote remyelination via PI3K/Akt/mTOR signaling in experimental multiple sclerosis.

Rohit Kumar Singh et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42622843